RLYB
RLYB
NASDAQ · Biotechnology

Rallybio Corp

$8.22
-0.22 (-2.61%)
As of Mar 29, 10:35 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +68.2% upside
Low Target $9.36
Average Target $13.83
High Target $17.78
Current Price $8.22
Current
$8.22
Target
$13.83
$9.36 $13.83 avg $17.78
Scenario Analysis
Bear Case
$9.36
13.9%
Low target
Base Case
$13.83
+68.2%
Avg target
Bull Case
$17.78
+116.3%
High target
Risk/Reward
8.4x
Highly favorable
Price in Context
52-Week High
$11.49
-28.5% from high
52-Week Low
$1.76
+367.0% from low
Target vs 52W High
$13.83
+20.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%